XML 142 R128.htm IDEA: XBRL DOCUMENT v3.21.1
SEGMENT INFORMATION - Schedule of Segment Reporting Information By Segment (Details) - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenues € 41,662 € 44,912 € 39,183
Cost of sales (23,283) (23,909) (22,266)
Gross profit 18,379 21,002 16,917
Research and development expenses (4,496) (3,728) (4,088)
Selling and marketing expenses (9,279) (10,850) (10,551)
General and administrative expenses (4,335) (4,224) (3,593)
Segment operating income (loss) 269 2,201 (1,315)
Total Assets 55,193 53,068  
Goodwill 2,412 2,412  
Product      
Revenues 41,649 44,859 39,163
RPP's and leases      
Revenues 4,745 5,747 5,086
Cost of sales (2,601) (3,000) (2,557)
Spare parts and services      
Revenues 9,382 9,001 9,007
Cost of sales (5,732) (5,467) (5,655)
FDA [Member]      
Revenues 41,662 44,912 39,183
Cost of sales (23,283) (23,909) (22,266)
Gross profit 18,379 21,002 16,917
Research and development expenses (4,496) (3,728) (4,088)
Selling and marketing expenses (9,279) (10,850) (10,551)
General and administrative expenses (4,335) (4,224) (3,593)
Total expenses (18,110) (18,802) (18,232)
Segment operating income (loss) 269 2,201 (1,316)
Total Assets 55,193 53,068 48,740
Capital expenditures 2,011 1,532 1,928
Long-lived assets 9,801 10,971 8,013
Goodwill 2,412 2,412 2,412
FDA [Member] | Product      
Revenues 27,523 30,111 25,070
FDA [Member] | RPP's and leases      
Revenues 4,745 5,747 5,086
FDA [Member] | Spare parts and services      
Revenues 9,382 9,001 9,007
FDA [Member] | Product and Services, Excluding Other      
Revenues 41,649 44,859 39,163
FDA [Member] | Other revenues      
Revenues 12 52 19
Operating Segments | High Intensity Focused Ultrasound (HIFU)      
Revenues 11,438 14,144 11,044
Cost of sales (5,144) (6,152) (5,312)
Gross profit 6,293 7,991 5,732
Research and development expenses (2,583) (1,962) (2,394)
Selling and marketing expenses (3,151) (4,402) (4,628)
General and administrative expenses (1,005) (1,168) (1,036)
Total expenses (6,738) (7,533) (8,057)
Segment operating income (loss) (445) 459 (2,325)
Total Assets 16,279 16,665 13,648
Capital expenditures 1,144 915 1,154
Long-lived assets 3,706 4,096 2,855
Goodwill 645 645 645
Operating Segments | High Intensity Focused Ultrasound (HIFU) | Product      
Revenues 6,000 8,311 5,494
Operating Segments | High Intensity Focused Ultrasound (HIFU) | RPP's and leases      
Revenues 3,594 4,162 3,750
Operating Segments | High Intensity Focused Ultrasound (HIFU) | Spare parts and services      
Revenues 1,831 1,618 1,780
Operating Segments | High Intensity Focused Ultrasound (HIFU) | Product and Services, Excluding Other      
Revenues 11,425 14,092 11,025
Operating Segments | High Intensity Focused Ultrasound (HIFU) | Other revenues      
Revenues 12 52 19
Operating Segments | Urology Devices and Services (ESWL)      
Revenues 12,882 14,190 14,480
Cost of sales (7,232) (7,816) (8,178)
Gross profit 5,649 6,374 6,302
Research and development expenses (1,555) (1,394) (1,410)
Selling and marketing expenses (2,052) (2,441) (2,357)
General and administrative expenses (964) (904) (731)
Total expenses (4,572) (4,738) (4,498)
Segment operating income (loss) 1,078 1,635 1,804
Total Assets 15,567 15,892 16,700
Capital expenditures 309 298 451
Long-lived assets 2,466 4,448 3,697
Goodwill 496 450 403
Operating Segments | Urology Devices and Services (ESWL) | Product      
Revenues 6,248 6,715 7,069
Operating Segments | Urology Devices and Services (ESWL) | RPP's and leases      
Revenues 927 1,426 1,254
Operating Segments | Urology Devices and Services (ESWL) | Spare parts and services      
Revenues 5,707 6,048 6,157
Operating Segments | Urology Devices and Services (ESWL) | Product and Services, Excluding Other      
Revenues 12,882 14,190 14,480
Operating Segments | Distribution (DISTRIB) Division [Member]      
Revenues 17,342 16,578 13,657
Cost of sales (10,906) (9,941) (8,775)
Gross profit 6,436 6,637 4,882
Research and development expenses (358) (372) (285)
Selling and marketing expenses (4,076) (4,008) (3,566)
General and administrative expenses (900) (854) (580)
Total expenses (5,335) (5,233) (4,431)
Segment operating income (loss) 1,102 1,404 451
Total Assets 20,795 16,500 13,149
Capital expenditures 557 319 324
Long-lived assets 3,628 2,427 1,462
Goodwill 1,271 1,317 1,364
Operating Segments | Distribution (DISTRIB) Division [Member] | Product      
Revenues 15,274 15,084 12,505
Operating Segments | Distribution (DISTRIB) Division [Member] | RPP's and leases      
Revenues 224 158 82
Operating Segments | Distribution (DISTRIB) Division [Member] | Spare parts and services      
Revenues 1,844 1,335 1,070
Operating Segments | Distribution (DISTRIB) Division [Member] | Product and Services, Excluding Other      
Revenues 17,342 16,578 13,657
Reconciling Items | EDAP Technomed Co Ltd. [Member]      
General and administrative expenses (1,465)   (1,247)
Total expenses (1,465)   (1,247)
Segment operating income (loss) (1,465)   (1,247)
Total Assets € 2,551 € 4,012 € 5,243